A BILL 
To amend title XIX of the Social Security Act to prohibit 
additional rebates under the Medicaid program for cer-
tain noninnovator multiple source drugs. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Protecting Access to 
4
Affordable Medicines Act of 2021’’. 
5
SEC. 2. PROHIBITION ON ADDITIONAL REBATE UNDER 
6
MEDICAID 
FOR 
CERTAIN 
NONINNOVATOR 
7
MULTIPLE SOURCE DRUGS. 
8
Section 1927(c)(3)(C) of the Social Security Act (42 
9
U.S.C. 1396r–8(c)(3)(C)) is amended— 
10
00:52 Jun 09, 2021
H2868
2 
•HR 2868 IH
(1) in clause (i), by striking ‘‘The amount’’ and 
1
inserting ‘‘Subject to clause (v), the amount’’; and 
2
(2) by adding at the end the following new 
3
clause: 
4
‘‘(v) PROHIBITION
ON
ADDITIONAL 
5
REBATE
FOR
CERTAIN
NONINNOVATOR 
6
MULTIPLE SOURCE DRUGS.—With respect 
7
to a rebate period beginning on or after 
8
January 1, 2022, and a dosage form and 
9
strength of a covered outpatient drug de-
10
scribed in clause (i), the amount of the re-
11
bate specified in subparagraph (A) for 
12
such dosage form and strength for such re-
13
bate period may not be increased if the av-
14
erage manufacturer price for a unit of 
15
such dosage form and strength for such re-
16
bate period is less than $1.’’. 
17
Æ 
00:52 Jun 09, 2021
H2868
